Advertisement

Gyros AB Gyrolab® xPand Articles

Image: Gyros Protein Technologies introduces Gyrolab xPand to improve immunoassay workflow, flexibility and speed in biotherapeutic discovery, development and production

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassay platforms and leading provider of peptide synthesizers and reagents, today introduced a new 5 CD model, Gyrolab® xPand, in response to customer requests to...

Image: Gyros Protein Technologies introduces multi-species kit for toxicokinetic studies

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic...